Siti Murdina, Rd Dina (2024) GAMBARAN PENGGUNAAN OBAT ANTIHIPERTENSI PADA PASIEN RAWAT JALAN DI RSUD DR SOEKARDJO TASIKMALAYA TAHUN 2023. Diploma thesis, POLITEKNIK KESEHATAN TASIKMALAYA.
![[img]](http://repo.poltekkestasikmalaya.ac.id/style/images/fileicons/text.png) |
Text (Halaman Depan)
HALAMAN PERNYATAAN ORSINILITAS.pdf Download (123kB) |
|
Text (Halaman Depan)
HALAMAN PENGESAHAN.pdf Download (202kB) |
|
Text (Halaman Depan)
HALAMAN PERSETUJUAN PUBLIKASI KARYA TULIS.pdf Download (616kB) |
|
Text (Halaman Depan)
HALAMAN JUDUL.pdf Download (390kB) |
|
Text (BAB I)
BAB 1.pdf Download (205kB) |
|
Text (BAB II)
BAB 2.pdf Restricted to Repository staff only Download (339kB) |
|
Text (BAB III)
BAB 3.pdf Restricted to Repository staff only Download (267kB) |
|
Text (BAB IV)
BAB 4.pdf Restricted to Repository staff only Download (320kB) |
|
Text (BAB V)
BAB 5.pdf Restricted to Repository staff only Download (186kB) |
|
Text (DAFTAR PUSTAKA)
DAFTAR PUSTAKA.pdf Restricted to Repository staff only Download (194kB) |
|
Text (LAMPIRAN)
LAMPIRAN.pdf Restricted to Repository staff only Download (992kB) |
Abstract
Hypertension is the greatest risk cause for cardiovascular disease and it increases in patients with diabetes mellitus and with chronic renal failure. The use of medication to control blood pressure is necessary to prevent complications due to hypertension. The aim of this research was to determine the use of antihypertensive drugs in outpatients at RSUD dr. Soekardjo in 2023. This research includes descriptive research that is cross sectional in nature with quantitative methods using purposive sampling techniques. The population of this study was medical record data from hypertensive patients and a sample of 196 samples. Characteristics of hypertensive patients based on hypertensive patients, age and gender. Characteristics of hypertension therapy based on group, active substance, route of administration, dose, and dosage form. The results of this study showed that the highest percentage was in the category of hypertensive patients without comorbidities, 85.8%, female gender 59.7% and age 41-59 years 49.3%. Based on the class and active substance of antihypertensive drugs in hypertensive patients without accompanying CCB (amlodipine) single therapy, it was 44.6% and for combination therapy with CCB (amlodipine) and ARB (valsartan) 7.1%. In hypertensive patients with accompanying diabetes mellitus, single therapy with CCB (amlodipine) was 35.7% and the combination of CCB (amlodipine) and ARB (valsartan) was 28.6%. In hypertensive patients with accompanying chronic renal failure, single therapy with ARB (irbesartan) was 7.1% and a combination of CCB (amlodipine) and diuretic (hydrochlorothiazide) was 35.7%. Based on the dose, namely amlodipine 1x10mg 50.0%, based on the oral administration route 100% and based on the tablet dosage form 100%.
| Item Type: | Thesis (Diploma) |
|---|---|
| Subjects: | R Medicine > R Medicine (General) R Medicine > RM Therapeutics. Pharmacology |
| Divisions: | Jurusan Farmasi > D3 Farmasi |
| Depositing User: | Mhs Rd Dina Siti Murdina |
| Date Deposited: | 21 Aug 2024 01:56 |
| Last Modified: | 21 Aug 2024 01:56 |
| URI: | http://repo.poltekkestasikmalaya.ac.id/id/eprint/4271 |
Actions (login required)
 |
View Item |